Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients

Host: John Buse, MD, PhD Guest: Helen Murphy, PhD There are many challenges associated with managing type 1 diabetes (T1D) in pregnant patients, which is why a recent study examined the use of an automated insulin delivery system in this patient population. Using this method, insulin doses were adjusted every 8 to 10 minutes according to a patient’s real-time glucose levels taken from her continuous glucose monitor. As a result, women experienced a higher percentage time in the pregnancy glucose target range, less hyperglycemia, and less gestational weight gain. Learn more about how these findings may impact the management of T1D both during and after pregnancy with Dr. John Buse and Dr. Helen Murphy, a Professor of Medicine in Diabetes and Antenatal Care at the University of East Anglia in the United Kingdom.

You can listen to Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients online on Radio and Podcast. Open the player on this page to stream the available audio.

Why Hybrid Closed-Loop Insulin Therapy Should Be Offered to Pregnant T1D Patients is an episode from Diabetes Discourse by ReachMD.

This episode is 00:11:30 long.

This episode was published on Nov 27, 2023.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Diabetes Discourse when more episodes are available from the podcast feed.